13-Employee SoCal Startup Bioniz Has A $400 Million Valuation Post author:Sam Post published:December 19, 2017 Post category:BioPharma Forbes recently interviewed Nazli Azimi, the CEO and co-founder of Bioniz Therapeutics. Source: BioSpace You Might Also Like Ramaswamy's Roivant Inks $650M R&D Deal With This Tiny Diabetes Biotech February 11, 2018 <b>GBSI</b> Biopolicy Summit 2017 Explores Newest Lab Automation, Digital Tools And Technologies Promising Improved Preclinical Research Reproducibility — October 16 In San Francisco September 6, 2017 Altimmune Expands to New HQ With Plans for New Jobs August 22, 2017
<b>GBSI</b> Biopolicy Summit 2017 Explores Newest Lab Automation, Digital Tools And Technologies Promising Improved Preclinical Research Reproducibility — October 16 In San Francisco September 6, 2017
